Research article Open access
Effects of Losartan vs. Enalapril on the Markers of Metabolic Syndrome
Al-Thanoon et al. reported that several markers of metabolic syndrome (MetS) were improved by the administration of losartan (50 mg/day) or enalapril (20 mg/day). A significant increase in high density lipoprotein cholesterol (HDL-C) was noted only with losartan. Some comments may be of interest. The Losartan Intervent …